Goldman Sachs Group »

Regulus Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $247k 139k 1.79
2024-03-31 $655k 227k 2.88

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Nvidia Corporation CMN (NVDA)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Amazon CMN (AMZN)
Alphabet CMN (GOOGL)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Ishares Tr CMN (IVV)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IWM)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Visa CMN (V)
Ishares Tr CMN (EEM)

View all positions for Goldman Sachs Group

Top funds holding Regulus Therapeutics

Federated Investors
NEA Management Company
Octagon Capital Advisors
BlackRock
Vanguard Group
BlackRock
Deep Track Capital
T. Rowe Price Associates
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Woodline Partners
DAFNA Capital Management
Point72 Asset Management
RA Capital Management

View all funds holding Regulus Therapeutics